We briefly review the surgical approaches to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2 (medullary thyroid carcinoma/multiple endocrine neoplasia type 2). The recommended surgical approaches are usually based on the age of the affected carrier/patient, tumor staging and the specific rearranged during transfection codon mutation. We have focused mainly on young children with no apparent disease who are carrying a germline rearranged during transfection mutation. Successful management of medullary thyroid carcinoma in these cases depends on early diagnosis and treatment. Total thyroidectomy should be performed before 6 months of age in infants carrying the rearranged during transfection 918 codon mutation,...
Medullary thyroid carcinoma (MTC) originates from thyroid parafollicular C cells, and it accounts fo...
textabstractBackground Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in ch...
Background. Germline missense point mutations of the ret proto-oncogene have been shown as causative...
We briefly review the surgical approaches to medullary thyroid carcinoma associated with multiple en...
Medullary thyroid carcinoma (MTC) is a rare, accounting for 5% of thyroid malignancies. It is a neur...
Abstract PURPOSE: Hereditary medullary thyroid carcinoma (MTC) therapy is surgical resection. Beca...
OBJECTIVE: Evaluation of treatment of children who are proven carriers of a multiple endocrine neopl...
Boybeyi-Turer O, Vuralli D, Karnak I, Gonc N, Yalcin ES, Orhan D, Kandemir N, Tanyel FC. Surgical an...
AIMS: To evaluate the value of prophylactic total thyroidectomy in multiple endocrine neoplasia 2a (...
Aims: Germline mutated RET proto-oncogene, causing multiple endocrine neoplasia (MEN)-2a syndrome is...
Department of Surgery, University Hospital of Maastricht, The Netherlands.BACKGROUND: Patients with ...
Medullary thyroid carcinoma (MTC) constitutes about 3-10% of all thyroid cancers. It arises from the...
Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in chromosome 10. All MEN 2 ...
BACKGROUND Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in chromosome 10....
Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in chromosome 10. All MEN 2 ...
Medullary thyroid carcinoma (MTC) originates from thyroid parafollicular C cells, and it accounts fo...
textabstractBackground Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in ch...
Background. Germline missense point mutations of the ret proto-oncogene have been shown as causative...
We briefly review the surgical approaches to medullary thyroid carcinoma associated with multiple en...
Medullary thyroid carcinoma (MTC) is a rare, accounting for 5% of thyroid malignancies. It is a neur...
Abstract PURPOSE: Hereditary medullary thyroid carcinoma (MTC) therapy is surgical resection. Beca...
OBJECTIVE: Evaluation of treatment of children who are proven carriers of a multiple endocrine neopl...
Boybeyi-Turer O, Vuralli D, Karnak I, Gonc N, Yalcin ES, Orhan D, Kandemir N, Tanyel FC. Surgical an...
AIMS: To evaluate the value of prophylactic total thyroidectomy in multiple endocrine neoplasia 2a (...
Aims: Germline mutated RET proto-oncogene, causing multiple endocrine neoplasia (MEN)-2a syndrome is...
Department of Surgery, University Hospital of Maastricht, The Netherlands.BACKGROUND: Patients with ...
Medullary thyroid carcinoma (MTC) constitutes about 3-10% of all thyroid cancers. It arises from the...
Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in chromosome 10. All MEN 2 ...
BACKGROUND Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in chromosome 10....
Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in chromosome 10. All MEN 2 ...
Medullary thyroid carcinoma (MTC) originates from thyroid parafollicular C cells, and it accounts fo...
textabstractBackground Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in ch...
Background. Germline missense point mutations of the ret proto-oncogene have been shown as causative...